Dialysis industry news

Stories from the dialysis comunity across the globe.



Mildly Elevated Blood Pressure May Raise Heart Risks in Middleage - Renal and Urology News PDF Print
July 07, 2015 Treatment should begin early to prevent cardiac dysfunction, researchers say.
Treatment should begin early to prevent cardiac dysfunction, researchers say.

(HealthDay News) -- Young adults with even slightly elevated blood pressure may be at risk of cardiac dysfunction later in life, according to a new study published in the Journal of the American College of Cardiology.

Researchers followed 2,479 men and women over the course of 25 years. They were between 18 and 30 years old when the study began. During the study period, researchers looked at the participants' health 7 times. Part of their evaluations included blood pressure readings. Towards the end of the study, the researchers also performed cardiac imaging tests.

The researchers found that participants who had slightly elevated blood pressure that was still considered within normal range when they were between 18 and 30 years old were more likely to have problems with their left ventricle once they reached middle age.

"Our findings provide further support for the importance of good risk factor control early in life," lead author João Lima, M.D., from the cardiology division at the Johns Hopkins University School of Medicine in Baltimore, said in a journal news release. "Many participants were not hypertensive at the beginning of the study; however, chronic exposure to higher blood pressure, even within what is considered the normal range, is associated with cardiac dysfunction 25 years later."

Sources

  1. Kishi, S, et al. J Am Coll Cardiol.2015;65(25):2679-2687. doi:10.1016/j.jacc.2015.04.042.
  2. Thomas H. Marwick and Alison J. Venn. Am Coll Cardiol., 2015;65(25):2688-2690; doi: 10.1016/j.jacc.2015.04.040.

...

 
Zacks Rating on DaVita healthCare Partners Inc. | OTC Outlook - OTC Outlook PDF Print

As much as 10 analysts have advised buy on DaVita healthCare Partners Inc. (NYSE:DVA) with an average broker rating of 1.8. Experts at Zacks have given it a short term rating of 2, which means that the investors can Buy for the short term positions.

DaVita healthCare Partners Inc. (NYSE:DVA) should head towards $89 per share according to 6 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $83 per share. The higher price estimate target is at $96 according to the Analysts. Currently the company Insiders own 0.2% of DaVita HealthCare Partners Inc. Company shares. In the past six months, there is a change of -58.01% in the total insider ownership. Institutional Investors own 86.6% of Company shares. During last 3 month period, 0% of total institutional ownership has changed in the company shares. DaVita healthCare Partners Inc. (NYSE:DVA) : On Monday heightened volatility was witnessed in DaVita healthCare Partners Inc. (NYSE:DVA) which led to swings in the share price. The shares opened for trading at $78.53 and hit $80.11 on the upside , eventually ending the session at $79.55, with a gain of 0.77% or 0.61 points. The heightened volatility saw the trading volume jump to 2,077,168 shares. The 52-week high of the share price is $85.17 and the company has a market cap of $17,099 million. The 52-week low of the share price is at $70.41 . The company shares have rallied 7.72% from its 1 Year high price. On Apr 27, 2015, the shares registered one year high at $85.17 and the one year low was seen on Jul 31, 2014. The 50-Day Moving Average price is $82.07 and the 200 Day Moving Average price is recorded at $79.11. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.

...

 
Zacks Rating on DaVita healthCare Partners Inc. - OTC Outlook PDF Print

As much as 10 analysts have advised buy on DaVita healthCare Partners Inc. (NYSE:DVA) with an average broker rating of 1.8. Experts at Zacks have given it a short term rating of 2, which means that the investors can Buy for the short term positions.

DaVita healthCare Partners Inc. (NYSE:DVA) should head towards $89 per share according to 6 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $83 per share. The higher price estimate target is at $96 according to the Analysts. Currently the company Insiders own 0.2% of DaVita HealthCare Partners Inc. Company shares. In the past six months, there is a change of -58.01% in the total insider ownership. Institutional Investors own 86.6% of Company shares. During last 3 month period, 0% of total institutional ownership has changed in the company shares. DaVita healthCare Partners Inc. (NYSE:DVA) : On Monday heightened volatility was witnessed in DaVita healthCare Partners Inc. (NYSE:DVA) which led to swings in the share price. The shares opened for trading at $78.53 and hit $80.11 on the upside , eventually ending the session at $79.55, with a gain of 0.77% or 0.61 points. The heightened volatility saw the trading volume jump to 2,077,168 shares. The 52-week high of the share price is $85.17 and the company has a market cap of $17,099 million. The 52-week low of the share price is at $70.41 . The company shares have rallied 7.72% from its 1 Year high price. On Apr 27, 2015, the shares registered one year high at $85.17 and the one year low was seen on Jul 31, 2014. The 50-Day Moving Average price is $82.07 and the 200 Day Moving Average price is recorded at $79.11. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.

...

 
Patients protest Brooklyn dialysis center closing - Brooklyn Daily Eagle PDF Print

The Brooklyn Kidney Center (BKC), a dialysis center in Park Slope, has notified patients and staff that it is closing its doors next month, leaving its patients – many in wheelchairs or otherwise disabled – scrambling to find seats in other centers in Brooklyn or elsewhere.

Patients and supporters rallied on Thursday outside the clinic at 184 Sterling Place. Chanting “Save our center!” they urged BKC's owner, Fresenius Medical Care, to delay the closing until a new facility on DeGraw Street is completed this fall. The new facility has experienced construction delays.

Fresenius spokesperson Jon Stone blames the building’s landlord for the closure.

“New York Dialysis Services has a strong record of providing patients with high quality, accessible dialysis care. Unfortunately, the landlord’s recent decision to sell the property will force the closure of Brooklyn Kidney Center, likely in mid-July. We were not asked to be involved in the transaction, and the sale of the building is not tied to the services we provide. We are disappointed to lose our current location, especially given the importance the center has to not only the patients it serves, but to the overall availability of dialysis within the community.”

Fortis Property Group obtained BKC’s building as part of SUNY’s controversial closure and sale of Long Island College Hospital (LICH). Supporters say the move is just another example of a medical facility in Brooklyn suddenly closing without community input or the needs of the patients being taken into consideration.

Patients protest Brooklyn dialysis center closing - Brooklyn Daily Eagle

While there are other Fresenius-owned clinics, supporters claim that Fresenius is giving priority to the 20 or so patents with private health insurance, leaving the roughly 150 Medicaid and Medicare patients to fend for themselves.

Stone says that claim is untrue. “Fresenius Medical Care is making efforts to assist all patients in transferring to new facilities,” he told the Brooklyn Eagle on Monday.

That news has yet to reach the patients. Joyce Corrica said she started dialysis at the age of 19. “I’ve been here for 42 years. And now, I was told two weeks ago that we have to evacuate because they were building a new building and it’s not finished. That’s not our responsibility. But they told us that we have to move and go to different centers. This is my health; this is my life.”

Corrica and other patients said they would have difficulty finding a new clinic, and felt their health would suffer.

“I trust the staff at BKC, I trust the people, the social workers,” she said. “I trust my dietician, I trust my doctor, Dr. Gan. I been knowing him since 1975. How could you send me someplace else to meet a new doctor who do not know anything about me? All we’re asking for is to let us stay here until the new place is finished in the fall.”

Cherie Walker, who has been receiving treatment at the center for 17 years, said, “This is not a job, this is our lifeline. Some people have been coming here for 15, 16 years. You built the Barclay up with no problem, right? Why are we still waiting after three and four years for our center to be built?”

Norma Soto said her whole life was being turned upside down. “All we ask for is an extension. Let them finish the new place; it’s just a few months.”

“We’re married to the staff here,” said Roy L. Hargrove. “It’s so unfair, it brings a grown man to tears. I feel like my wife just left me and ran off with [another man].”

He added, “They’re going to have to chain the door. Hell, no, we won’t go!”

Adrian, who uses a wheelchair, said patients were being pushed out as a result of gentrification.

“I’ve been coming here 17 years. It’s all about the money. We’re just asking for an extension,” he said, as the crowd shouted in agreement, “That’s all we ask for!”

Patients and staff applauded Assemblymember Jo Anne Simon for her sponsorship of the LICH Act, which would prevent the closing of health facilities without community input and an assessment of the health needs of the area. But the act hasn’t yet passed in the Senate and so does not apply to BKC.

“This is a consequence of the LICH deal,” Simon said. “A consolidated kidney center is about to open but there have been construction delays.”

Patients protest Brooklyn dialysis center closing - Brooklyn Daily Eagle Pushing people out “will compromise care and lives,” Simon said. “Most of them are on Medicaid and Medicare, and many need assisted transportation. People are being put in the street. This center is vital – you can’t just go off dialysis for a couple of days. It seems unduly harsh to go ahead with the sale.”

She added that BKC has a “highly trained staff, and they’re being fired.”

Stone said Medical Care, New York Dialysis Services' parent company, is “working diligently to relocate our affected patients to other nearby facilities and to minimize the impact to our employees.”

...

 
Medical Identity Theft on the Rise - Renal and Urology News PDF Print
July 06, 2015 Sitting Harms Health Even With Exercise
Sitting Harms Health Even With Exercise

(HealthDay News) -- Medical identity theft is on the rise, costly to consumers, and challenging to resolve, according to the fifth annual report published by the Ponemon Institute.

The researchers examined how pervasive identity theft is in the United States, its effect, and measures that can be taken to prevent its proliferation. The research was funded by the Medical Identity Fraud Alliance; data were obtained from 1,005 survey responses for 2014.

According to the report, there was a 21.7% increase in medical identity thefts since the previous report. Medical identity theft is costly to consumers, with 65% of victims having to pay an average of $13,500 to resolve the crime. The victim of theft is rarely informed by the health care provider or insurer; however, due to privacy issues, victims must be involved in the resolution of the crime. 

Only 10% of respondents reported satisfactory outcomes. Victims of medical identity theft report a negative impact on their reputation, often due to disclosure of sensitive personal health conditions. Consumers expect health care providers to be proactive in preventing and detecting medical identity fraud.

"Consumers should be informed about what they can do to prevent medical identity theft, including protecting their credentials from family and friends, monitoring their health care records, and paying attention to insurance claims for possible signs their identity has been compromised," the Ponemon Institute states in the report.

Source

Fifth Annual Study on Medical Identity Theft, Feb 2015.

...

 
<< Start < Prev 111 112 113 114 115 116 117 118 119 120 Next > End >>

Page 115 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.